Evidence of parallels between mercury intoxication and the brain pathology in autism.

Institute of Chronic Illnesses, Inc., Silver Spring, MD, USA.
Acta neurobiologiae experimentalis (Impact Factor: 2.24). 01/2012; 72(2):113-53.
Source: PubMed

ABSTRACT The purpose of this review is to examine the parallels between the effects mercury intoxication on the brain and the brain pathology found in autism spectrum disorder (ASD). This review finds evidence of many parallels between the two, including: (1) microtubule degeneration, specifically large, long-range axon degeneration with subsequent abortive axonal sprouting (short, thin axons); (2) dentritic overgrowth; (3) neuroinflammation; (4) microglial/astrocytic activation; (5) brain immune response activation; (6) elevated glial fibrillary acidic protein; (7) oxidative stress and lipid peroxidation; (8) decreased reduced glutathione levels and elevated oxidized glutathione; (9) mitochondrial dysfunction; (10) disruption in calcium homeostasis and signaling; (11) inhibition of glutamic acid decarboxylase (GAD) activity; (12) disruption of GABAergic and glutamatergic homeostasis; (13) inhibition of IGF-1 and methionine synthase activity; (14) impairment in methylation; (15) vascular endothelial cell dysfunction and pathological changes of the blood vessels; (16) decreased cerebral/cerebellar blood flow; (17) increased amyloid precursor protein; (18) loss of granule and Purkinje neurons in the cerebellum; (19) increased pro-inflammatory cytokine levels in the brain (TNF-α, IFN-γ, IL-1β, IL-8); and (20) aberrant nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB). This review also discusses the ability of mercury to potentiate and work synergistically with other toxins and pathogens in a way that may contribute to the brain pathology in ASD. The evidence suggests that mercury may be either causal or contributory in the brain pathology in ASD, possibly working synergistically with other toxic compounds or pathogens to produce the brain pathology observed in those diagnosed with an ASD.


Available from: Mark R Geier, Jun 03, 2015
1 Follower
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dilek Kaya Akyuzlu, Zeliha Kayaalti, Esma Soylemez and Tulin Soylemezoglu
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Selenium (Se) is an essential trace element for humans. It is found in the enzyme glutathione peroxidase. This enzyme protects the organism against certain types of damage. Some data suggest that Se plays a role in the body's metabolism of mercury (Hg). Selenium has in some studies been found to reduce the toxicity of Hg salts. Selenium and Hg bind in the body to each other. It is not totally clear what impact the amount of Se has in the human body on the metabolism and toxicity of prolonged Hg exposure.
    BioMetals 05/2015; DOI:10.1007/s10534-015-9857-5 · 2.69 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The majority of the heme-binding proteins possess a “heme-pocket” that binds irreversibly with heme. These are usually known as housekeeping heme-proteins that participate in a variety of enzymatic reactions (e.g., catalase). Heme also binds with lower affinity to “Heme-Regulatory Motif” (HRM) in specific regulatory proteins. This type of heme binding is known as exchangeable or regulatory heme (RH). The binding of heme with HRM-possessing proteins regulates their function (e.g., Bach1). Although there are well-established methods for assaying total cellular heme (e.g., heme-proteins and RH), currently there is no method available for measuring RH independently from the total heme (TH). The current study describes and validates a new method to measure intracellular RH. The method is based on the reconstitution of apo-horseradish peroxidase (apoHRP) with heme to form holoHRP. The resulting holoHRP activity is then measured with colorimetric substrate. The study shows that apoHRP specifically reconstitutes with RH but not with heme from housekeeping heme-proteins. The study also examines if the assay detects intracellular RH using human normal fibroblasts (IMR90). For this purpose, IMR90 cells were exposed to conditions that create positive (hemin) or negative (NMP) controls for heme and examined the impact on RH and TH. Subcytotoxic concentrations of lead (Pb), mercury (Hg), and amyloid-β (Aβ) alter intracellular RH with no effect on TH. In conclusion the RH assay allows the investigation of intracellular RH and shows that RH is a dynamic fraction of intracellular heme and it makes about 6% of the TH in IMR90.
    Metallomics 12/2014; 7(2). DOI:10.1039/C4MT00246F · 3.98 Impact Factor